New sleep aid APSTZD put to the test in Mid-Stage trial
NCT ID NCT07420816
First seen Feb 23, 2026 · Last updated Apr 30, 2026 · Updated 13 times
Summary
This study tests a new insomnia drug, APSTZD, to see if it helps people stay asleep. About 222 adults with chronic insomnia will receive either APSTZD, an active comparator, or a placebo for 6 weeks. The main goal is to measure how much time they spend awake after falling asleep, using overnight sleep tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UNIFAG - Casa Nossa Senhora da PAZ -ASF
Bragança Paulista, São Paulo, 12916-900, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.